Submit Deal

KEENOVA THERAPEUTICS (EX-MALLINCKRODT PLC)

HQ - Staines-upon-Thames

Summary

Mallinckrodt Pharmaceuticals is an American-Irish domiciled manufacturer of specialty pharmaceuticals, generic drugs and imaging agents.

Deals Overview

Total Deals9

Valued Deals7

Total Value£ 9.93 B

Avg. Deal Size£ 1.42 B

Market Context

Senior Management

Mark Trudeau
President and CEO
Bryan Reasons
CFO
Steven Romano
Chief Scientific Officer and Executive Vice President

Sort

24 Aug 2016|United Kingdom|Pharmaceuticals

Target: MALLINCKRODT NUCLEAR IMAGING

Bidder: IBA MOLECULAR

3 Service Providers

1 Target | 2 Vendor

14 Dealmakers

14 Vendor

£ 520 M

Value

27 Jul 2015|United Kingdom|Medical Equipment

Target: KEENOVA THERAPEUTICS (EX-MALLINCKRODT PLC)

Bidder: GUERBET SA

1 Service Providers

1 Target

5 Dealmakers

5 Target

n/a

Value

10 Sep 2019|Canada|Pharmaceuticals

Target: BIOVECTRA INC

Bidder: HIG CAPITAL LLC

8 Service Providers

1 Target | 3 Bidder | 4 Vendor

8 Dealmakers

2 Target | 1 Bidder | 5 Vendor

£ 202 M

Value

05 Mar 2015|United States|Biotechnology

Target: IKARIA

Bidder: KEENOVA THERAPEUTICS (EX-MALLINCKRODT PLC)

6 Service Providers

2 Target | 4 Bidder

8 Dealmakers

2 Target | 6 Bidder

£ 1.54 B

Value

28 Sep 2015|United States|Medical Equipment

Target: THERAKOS

Bidder: KEENOVA THERAPEUTICS (EX-MALLINCKRODT PLC)

2 Service Providers

2 Bidder

5 Dealmakers

5 Bidder

£ 873 M

Value

26 Dec 2017|United States|Pharmaceuticals

Target: SUCAMPO PHARMACEUTICALS

Bidder: KEENOVA THERAPEUTICS (EX-MALLINCKRODT PLC)

6 Service Providers

3 Target | 3 Bidder

9 Dealmakers

2 Target | 7 Bidder

£ 897 M

Value

05 Aug 2024|United Kingdom|Pharmaceuticals

Target: MALLINCKRODT PLC (THERAKOS BUSINESS)

Bidder: CVC CAPITAL PARTNERS

11 Service Providers

5 Bidder | 6 Vendor

93 Dealmakers

24 Bidder | 69 Vendor

£ 722 M

Value

13 Mar 2025|United States|Pharmaceuticals

Target: ENDO INTERNATIONAL

Bidder: KEENOVA THERAPEUTICS (EX-MALLINCKRODT PLC)

16 Service Providers

6 Target | 10 Bidder

130 Dealmakers

26 Target | 104 Bidder

£ 5.17 B

Value

13 Mar 2025|United States|Pharmaceuticals

Target: PAR HEALTH

Bidder: INSTITUTIONAL INVESTORS

6 Service Providers

2 Target | 4 Vendor

27 Dealmakers

7 Target | 22 Vendor

n/a

Value